vs
Side-by-side financial comparison of AbbVie (ABBV) and Marathon Petroleum (MPC). Click either name above to swap in a different company.
Marathon Petroleum is the larger business by last-quarter revenue ($32.6B vs $15.0B, roughly 2.2× AbbVie). Marathon Petroleum runs the higher net margin — 4.7% vs 4.6%, a 0.1% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs -1.7%). Over the past eight quarters, AbbVie's revenue compounded faster (1.8% CAGR vs -0.2%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Marathon Petroleum Corporation is an American petroleum refining, marketing, and transportation company headquartered in Findlay, Ohio. The company was a wholly owned subsidiary of Marathon Oil until a corporate spin-off in 2011.
ABBV vs MPC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $15.0B | $32.6B |
| Net Profit | $697.0M | $1.5B |
| Gross Margin | — | 11.4% |
| Operating Margin | 26.6% | 8.3% |
| Net Margin | 4.6% | 4.7% |
| Revenue YoY | 9.9% | -1.7% |
| Net Profit YoY | -45.9% | 313.7% |
| EPS (diluted) | $0.39 | $4.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | — | ||
| Q4 25 | $16.6B | $32.6B | ||
| Q3 25 | $15.8B | $34.8B | ||
| Q2 25 | $15.4B | $33.8B | ||
| Q1 25 | $13.3B | $31.5B | ||
| Q4 24 | $15.1B | $33.1B | ||
| Q3 24 | $14.5B | $35.1B | ||
| Q2 24 | $14.5B | $37.9B |
| Q1 26 | $697.0M | — | ||
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $186.0M | $1.4B | ||
| Q2 25 | $938.0M | $1.2B | ||
| Q1 25 | $1.3B | $-74.0M | ||
| Q4 24 | $-22.0M | $371.0M | ||
| Q3 24 | $1.6B | $622.0M | ||
| Q2 24 | $1.4B | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | 72.6% | 11.4% | ||
| Q3 25 | 66.4% | 10.4% | ||
| Q2 25 | 71.8% | 11.2% | ||
| Q1 25 | 70.0% | 6.8% | ||
| Q4 24 | 70.9% | 7.8% | ||
| Q3 24 | 70.9% | 8.4% | ||
| Q2 24 | 70.9% | 10.5% |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 27.3% | 8.3% | ||
| Q3 25 | 12.1% | 7.8% | ||
| Q2 25 | 31.7% | 6.5% | ||
| Q1 25 | 28.0% | 2.2% | ||
| Q4 24 | -9.9% | 3.4% | ||
| Q3 24 | 26.5% | 3.8% | ||
| Q2 24 | 27.6% | 6.7% |
| Q1 26 | 4.6% | — | ||
| Q4 25 | 10.9% | 4.7% | ||
| Q3 25 | 1.2% | 3.9% | ||
| Q2 25 | 6.1% | 3.6% | ||
| Q1 25 | 9.6% | -0.2% | ||
| Q4 24 | -0.1% | 1.1% | ||
| Q3 24 | 10.8% | 1.8% | ||
| Q2 24 | 9.5% | 4.0% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.02 | $4.99 | ||
| Q3 25 | $0.10 | $4.51 | ||
| Q2 25 | $0.52 | $3.96 | ||
| Q1 25 | $0.72 | $-0.24 | ||
| Q4 24 | $-0.03 | $1.30 | ||
| Q3 24 | $0.88 | $1.87 | ||
| Q2 24 | $0.77 | $4.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $3.7B |
| Total DebtLower is stronger | — | $30.5B |
| Stockholders' EquityBook value | — | $17.3B |
| Total Assets | — | $84.0B |
| Debt / EquityLower = less leverage | — | 1.76× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.3B | $3.7B | ||
| Q3 25 | $5.7B | $2.7B | ||
| Q2 25 | $6.5B | $1.7B | ||
| Q1 25 | $5.2B | $3.8B | ||
| Q4 24 | $5.6B | $3.2B | ||
| Q3 24 | $7.3B | $5.1B | ||
| Q2 24 | $13.2B | $8.5B |
| Q1 26 | — | — | ||
| Q4 25 | $58.9B | $30.5B | ||
| Q3 25 | $63.0B | $31.2B | ||
| Q2 25 | $63.0B | $26.8B | ||
| Q1 25 | $64.5B | $26.8B | ||
| Q4 24 | $60.3B | $24.4B | ||
| Q3 24 | $58.5B | $24.1B | ||
| Q2 24 | $58.0B | $24.0B |
| Q1 26 | — | — | ||
| Q4 25 | $-3.3B | $17.3B | ||
| Q3 25 | $-2.6B | $17.1B | ||
| Q2 25 | $-183.0M | $16.6B | ||
| Q1 25 | $1.4B | $16.4B | ||
| Q4 24 | $3.3B | $17.7B | ||
| Q3 24 | $6.0B | $18.9B | ||
| Q2 24 | $6.8B | $21.3B |
| Q1 26 | — | — | ||
| Q4 25 | $134.0B | $84.0B | ||
| Q3 25 | $133.9B | $83.2B | ||
| Q2 25 | $137.2B | $78.5B | ||
| Q1 25 | $136.2B | $81.6B | ||
| Q4 24 | $135.2B | $78.9B | ||
| Q3 24 | $143.4B | $79.8B | ||
| Q2 24 | $141.9B | $85.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.76× | ||
| Q3 25 | — | 1.83× | ||
| Q2 25 | — | 1.61× | ||
| Q1 25 | 45.44× | 1.64× | ||
| Q4 24 | 18.15× | 1.38× | ||
| Q3 24 | 9.70× | 1.27× | ||
| Q2 24 | 8.56× | 1.13× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $3.1B |
| Free Cash FlowOCF − Capex | — | $1.9B |
| FCF MarginFCF / Revenue | — | 5.8% |
| Capex IntensityCapex / Revenue | — | 3.6% |
| Cash ConversionOCF / Net Profit | — | 2.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.8B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | $3.1B | ||
| Q3 25 | $7.0B | $2.6B | ||
| Q2 25 | $5.2B | $2.6B | ||
| Q1 25 | $1.6B | $-64.0M | ||
| Q4 24 | $7.0B | $2.2B | ||
| Q3 24 | $5.4B | $1.7B | ||
| Q2 24 | $2.3B | $3.2B |
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $1.9B | ||
| Q3 25 | $6.6B | $1.7B | ||
| Q2 25 | $4.9B | $1.9B | ||
| Q1 25 | $1.4B | $-727.0M | ||
| Q4 24 | $6.8B | $1.4B | ||
| Q3 24 | $5.2B | $1.0B | ||
| Q2 24 | $2.0B | $2.8B |
| Q1 26 | — | — | ||
| Q4 25 | 29.4% | 5.8% | ||
| Q3 25 | 42.1% | 4.8% | ||
| Q2 25 | 31.7% | 5.8% | ||
| Q1 25 | 10.5% | -2.3% | ||
| Q4 24 | 44.7% | 4.2% | ||
| Q3 24 | 35.9% | 2.9% | ||
| Q2 24 | 14.0% | 7.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 3.6% | ||
| Q3 25 | 2.4% | 2.7% | ||
| Q2 25 | 1.7% | 2.1% | ||
| Q1 25 | 1.8% | 2.1% | ||
| Q4 24 | 1.9% | 2.4% | ||
| Q3 24 | 1.7% | 1.9% | ||
| Q2 24 | 1.7% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.87× | 2.00× | ||
| Q3 25 | 37.76× | 1.90× | ||
| Q2 25 | 5.49× | 2.17× | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | — | 5.95× | ||
| Q3 24 | 3.49× | 2.71× | ||
| Q2 24 | 1.66× | 2.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
MPC
| Refined Products | $28.6B | 88% |
| Midstream | $1.4B | 4% |
| Crude Oil | $1.2B | 4% |
| Renewable Diesel | $851.0M | 3% |
| Related Party | $536.0M | 2% |
| Services & Other | $466.0M | 1% |